Life

Life Business Vision

In the Life organization, we established the business vision "We will lead the world in advancing Bio Industrial Autonomy and contribute to a future embracing global harmony" with the aim of clarifying future developments of the business, its scope and direction. In this vision, we have targeted the "Pharmaceutical, Food, Beverage & Biotech" sectors and aim to further expand our business, centering on theseindustries, by taking advantage of our strengths in "Measurement, Imaging, Analysis, Diagnosis, Integration" and Yokogawa core technologies.

Four business segments aiming to realize BIA

Life science

By contributing to the development of measurement and analysis technologies, we will solve problems that limit research progress and create a world where scientists can concentrate on science.

Bioprocess

Using real-time monitoring and software innovations, we will create a virtual world of "Digital Twin" where experimental simulations are leveraged  to realize precision predictive control

Pharmaceutical

We analyze and control the information obtained from all manufacturing activities and solve issues related to raw material quality, facility degradation, transmission of technology, and production processes to improve work environment and worker safety.

Food & Beverage

In addition to improving optimal and efficient automatic processes based on demand forecasting, we will assist with quality improvements that include taste attributes, and promote autonomous operation that grows independent of human intervention.
 

Life Business Headquarters’ contribution towards the fight against Novel Coronavirus Disease (COVID-19)

Yokogawa established the Life Business Headquarters with the goal of promoting well-being for all. In addition to engaging in our existing life science and manufacturing solutions businesses targeting the pharmaceutical and food industries, the headquarters works to develop new products and services and provides one-stop solutions that revolutionize productivity throughout the pharmaceutical and food industry value chain, from basic research to manufacturing, logistics, and services.

Yokogawa has more than 30 years’ experience in the life science field. The CSU spinning disk confocal scanner series is our core strength, and over 3,000 units have been sold globally. Other products, including a live cell imaging system, a high-content analysis system and single cell analysis solution also support leading life science studies. In the field of manufacturing solutions, over 1,000 Yokogawa manufacturing, production, and quality management systems and control systems have been introduced in the pharmaceutical industry.

In response to the novel coronavirus (COVID-19), Yokogawa has been taking various measures to prevent transmission of the virus while working to minimize the impact on customers. We are also contributing to the fight against COVID-19 by collaborating with research institutes globally and supporting research to develop new medication or vaccines. Yokogawa will continue to work with customers and business partners in an effort to resolve the crisis society is facing.

Please contact our sales and service representatives if you have any interest in our products, or you can send inquiries from the form below.

In August 2017, Yokogawa announced its long-term sustainability goals (Three Goals) for the　year 2050. Yokogawa established these goals to contribute to achieving Net-zero emissions,　Circular economy and Well-being. In April 2018, Yokogawa strengthened the business　structure of its life business with the aim of achieving one of these goals,　well-being.

Achieve a Well-being

• With the world’s population aging, the importance of　the pharmaceutical and food industries to ensure that people can live safe and secure lives with peace of mind is growing.
• With the world’s population increasing and aging in　major countries including emerging countries, it will　certainly become more difficult to stably supply the　necessary medical care and safe food to many people.
• In the 2030 Agenda for Sustainable Development, adopted by the United Nations in 2015, well-being is defined as a “state of physical, mental and social well being.” Yokogawa supports people’s health and prosperity, as well as a safe and comfortable workplace, in a wide range of fields, such as life sciences and drug discovery.
  
  
   

Establish a life business

• Expand business based on existing pharmaceutical/food industry businesses and new technologies and products that are under development.
• Through the use of measurement, control, and information technology, radically improve productivity across the entire value chain, from basic research to logistics and services.
  
  

We post our information to the following SNSs.
Please follow us.

Yokogawa Life Science

Yokogawa's Official Social Media Account List

Social Media Account List